150 related articles for article (PubMed ID: 34326378)
1. Tumor collagen framework from bright-field histology images predicts overall survival of breast carcinoma patients.
Morkunas M; Zilenaite D; Laurinaviciene A; Treigys P; Laurinavicius A
Sci Rep; 2021 Jul; 11(1):15474. PubMed ID: 34326378
[TBL] [Abstract][Full Text] [Related]
2. High fibroblast growth factor 19 (FGF19) expression predicts worse prognosis in invasive ductal carcinoma of breast.
Buhmeida A; Dallol A; Merdad A; Al-Maghrabi J; Gari MA; Abu-Elmagd MM; Chaudhary AG; Abuzenadah AM; Nedjadi T; Ermiah E; Al-Thubaity F; Al-Qahtani MH
Tumour Biol; 2014 Mar; 35(3):2817-24. PubMed ID: 24248542
[TBL] [Abstract][Full Text] [Related]
3. Large-scale tumor-associated collagen signatures identify high-risk breast cancer patients.
Xi G; Guo W; Kang D; Ma J; Fu F; Qiu L; Zheng L; He J; Fang N; Chen J; Li J; Zhuo S; Liao X; Tu H; Li L; Zhang Q; Wang C; Boppart SA; Chen J
Theranostics; 2021; 11(7):3229-3243. PubMed ID: 33537084
[TBL] [Abstract][Full Text] [Related]
4. Aligned collagen is a prognostic signature for survival in human breast carcinoma.
Conklin MW; Eickhoff JC; Riching KM; Pehlke CA; Eliceiri KW; Provenzano PP; Friedl A; Keely PJ
Am J Pathol; 2011 Mar; 178(3):1221-32. PubMed ID: 21356373
[TBL] [Abstract][Full Text] [Related]
5. Cytoplasmic Skp2 expression is associated with p-Akt1 and predicts poor prognosis in human breast carcinomas.
Liu J; Wei XL; Huang WH; Chen CF; Bai JW; Zhang GJ
PLoS One; 2012; 7(12):e52675. PubMed ID: 23300741
[TBL] [Abstract][Full Text] [Related]
6. Extracellular matrix 1 (ECM1) expression is a novel prognostic marker for poor long-term survival in breast cancer: a Hospital-based Cohort Study in Iowa.
Lal G; Hashimi S; Smith BJ; Lynch CF; Zhang L; Robinson RA; Weigel RJ
Ann Surg Oncol; 2009 Aug; 16(8):2280-7. PubMed ID: 19521735
[TBL] [Abstract][Full Text] [Related]
7. Progranulin (GP88) tumor tissue expression is associated with increased risk of recurrence in breast cancer patients diagnosed with estrogen receptor positive invasive ductal carcinoma.
Serrero G; Hawkins DM; Yue B; Ioffe O; Bejarano P; Phillips JT; Head JF; Elliott RL; Tkaczuk KR; Godwin AK; Weaver J; Kim WE
Breast Cancer Res; 2012 Feb; 14(1):R26. PubMed ID: 22316048
[TBL] [Abstract][Full Text] [Related]
8.
Groheux D; Martineau A; Teixeira L; Espié M; de Cremoux P; Bertheau P; Merlet P; Lemarignier C
Breast Cancer Res; 2017 Jan; 19(1):3. PubMed ID: 28057031
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of bcl-2 expression among women with breast cancer in Libya.
Ermiah E; Buhmeida A; Khaled BR; Abdalla F; Salem N; Pyrhönen S; Collan Y
Tumour Biol; 2013 Jun; 34(3):1569-78. PubMed ID: 23417836
[TBL] [Abstract][Full Text] [Related]
10. Low expression of ULK1 is associated with operable breast cancer progression and is an adverse prognostic marker of survival for patients.
Tang J; Deng R; Luo RZ; Shen GP; Cai MY; Du ZM; Jiang S; Yang MT; Fu JH; Zhu XF
Breast Cancer Res Treat; 2012 Jul; 134(2):549-60. PubMed ID: 22585231
[TBL] [Abstract][Full Text] [Related]
11. Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma.
Grann VR; Troxel AB; Zojwalla NJ; Jacobson JS; Hershman D; Neugut AI
Cancer; 2005 Jun; 103(11):2241-51. PubMed ID: 15844176
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of circulating tumor cells (CTCs) with respect to optimal cut-off value and tumor markers in advanced/metastatic breast cancer.
Shiomi-Mouri Y; Kousaka J; Ando T; Tetsuka R; Nakano S; Yoshida M; Fujii K; Akizuki M; Imai T; Fukutomi T; Kobayashi K
Breast Cancer; 2016 Jan; 23(1):120-127. PubMed ID: 24906662
[TBL] [Abstract][Full Text] [Related]
13. Collagen analysis by second-harmonic generation microscopy predicts outcome of luminal breast cancer.
Natal RA; Vassallo J; Paiva GR; Pelegati VB; Barbosa GO; Mendonça GR; Bondarik C; Derchain SF; Carvalho HF; Lima CS; Cesar CL; Sarian LO
Tumour Biol; 2018 Apr; 40(4):1010428318770953. PubMed ID: 29663855
[TBL] [Abstract][Full Text] [Related]
14. Loss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failure.
Peck AR; Witkiewicz AK; Liu C; Stringer GA; Klimowicz AC; Pequignot E; Freydin B; Tran TH; Yang N; Rosenberg AL; Hooke JA; Kovatich AJ; Nevalainen MT; Shriver CD; Hyslop T; Sauter G; Rimm DL; Magliocco AM; Rui H
J Clin Oncol; 2011 Jun; 29(18):2448-58. PubMed ID: 21576635
[TBL] [Abstract][Full Text] [Related]
15. The value of COX-2 expression in the prognostic parameters of invasive ductal carcinoma of the breast.
Barısık NO; Keser SH; Gul AE; Sensu S; Kandemir NO; Kucuk HF; Gumus M; Karadayı N
Med Oncol; 2011 Sep; 28(3):703-8. PubMed ID: 20354817
[TBL] [Abstract][Full Text] [Related]
16. Ki67/SATB1 ratio is an independent prognostic factor of overall survival in patients with early hormone receptor-positive invasive ductal breast carcinoma.
Laurinavicius A; Green AR; Laurinaviciene A; Smailyte G; Ostapenko V; Meskauskas R; Ellis IO
Oncotarget; 2015 Dec; 6(38):41134-45. PubMed ID: 26512778
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer-specific survival in patients with lymph node-positive hormone receptor-positive invasive breast cancer and Oncotype DX Recurrence Score results in the SEER database.
Roberts MC; Miller DP; Shak S; Petkov VI
Breast Cancer Res Treat; 2017 Jun; 163(2):303-310. PubMed ID: 28243896
[TBL] [Abstract][Full Text] [Related]
18. Targeted matrisome analysis identifies thrombospondin-2 and tenascin-C in aligned collagen stroma from invasive breast carcinoma.
Tomko LA; Hill RC; Barrett A; Szulczewski JM; Conklin MW; Eliceiri KW; Keely PJ; Hansen KC; Ponik SM
Sci Rep; 2018 Aug; 8(1):12941. PubMed ID: 30154546
[TBL] [Abstract][Full Text] [Related]
19. Identification of prognostic collagen signatures and potential therapeutic stromal targets in canine mammary gland carcinoma.
Case A; Brisson BK; Durham AC; Rosen S; Monslow J; Buza E; Salah P; Gillem J; Ruthel G; Veluvolu S; Kristiansen V; Puré E; Brown DC; Sørenmo KU; Volk SW
PLoS One; 2017; 12(7):e0180448. PubMed ID: 28683102
[TBL] [Abstract][Full Text] [Related]
20. Computer-assisted quantification of tumor-associated collagen signatures to improve the prognosis prediction of breast cancer.
Xi G; Qiu L; Xu S; Guo W; Fu F; Kang D; Zheng L; He J; Zhang Q; Li L; Wang C; Chen J
BMC Med; 2021 Nov; 19(1):273. PubMed ID: 34789257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
